How to Get CagriSema Online in Antwerp
Searching for CagriSema online in Antwerp? While this promising weight-loss peptide is still in clinical trials and not yet approved for prescription in the EU, Hi-Doctor does not offer it.

How to Get CagriSema Online in Antwerp
If you're searching for CagriSema online in Antwerp, it's important to understand its current status. CagriSema is an investigational drug and is not yet approved for weight-loss prescription in the EU. Consequently, Hi-Doctor does not currently prescribe or offer CagriSema. However, your interest in advanced weight management is valid. Here’s what CagriSema actually is, why it's not a standard option today, and what proven, approved weight-loss treatments you CAN get from an EU-licensed doctor through Hi-Doctor today.
What is CagriSema, and why isn't it a normal option yet?
CagriSema is a novel weight-loss medication combining two active ingredients: semaglutide (a GLP-1 receptor agonist) and cagrilintide (an amylin analogue). This dual-action approach aims to suppress appetite and improve metabolic control. While early clinical trial results have shown significant promise for weight reduction, CagriSema is still in advanced stages of clinical development. It has not yet received marketing authorization from the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for weight management. This means it cannot be legally prescribed or sold as a standard medication in Antwerp or anywhere in the EU. Be wary of any online sources claiming to offer CagriSema; these are unregulated and pose significant health risks due to unknown purity, dosage, and potential contaminants.
Proven weight-loss medications available online today
- Ozempic (semaglutide): A GLP-1 receptor agonist, often prescribed for type 2 diabetes but also effective for weight management, available at specific doses.
- Wegovy (semaglutide): A higher-dose formulation of semaglutide specifically approved for chronic weight management in adults with obesity or overweight and related conditions.
- Mounjaro (tirzepatide): A dual GIP and GLP-1 receptor agonist, approved for type 2 diabetes, showing significant weight-loss benefits and available off-label for weight management.
- Saxenda (liraglutide): A daily GLP-1 receptor agonist, approved for chronic weight management, suitable for those who prefer a daily injection.
Each of these medications has a strong evidence base for safety and efficacy when prescribed and monitored by a qualified medical professional.
How to get a weight-loss prescription online in Belgium
Hi-Doctor makes accessing approved weight-loss treatments straightforward and safe, even from Antwerp. Our process ensures you receive care from an EU-licensed doctor:
- Complete an online medical questionnaire: This takes just 2–3 minutes and gathers essential information about your health and medical history.
- EU-licensed doctor reviews your case: An experienced Hi-Doctor physician will carefully assess your questionnaire to determine if a weight-loss medication is appropriate and safe for you.
- Receive your REMPE prescription in <24 hours: If approved, your doctor will issue a valid electronic prescription (REMPE, Spanish standard, valid EU-wide) within 24 hours. This is delivered as a downloadable PDF to your private account and by email. If treatment is not appropriate, your €25 consultation fee is automatically refunded.
- Pick up at any EU pharmacy: You can print your prescription or show it on your phone at any pharmacy in Belgium or across the EU, thanks to cross-border prescription directive 2011/24/EU.
The online consultation costs a flat rate of €25, with a money-back guarantee if treatment is not deemed suitable.
Why choose Hi-Doctor over unregulated peptide sellers
When considering weight-loss treatments, safety and legitimacy are paramount. Choosing Hi-Doctor ensures you benefit from:
- EU-licensed doctors: All consultations and prescriptions are handled by qualified medical professionals licensed within the European Union.
- Real medications, real pharmacies: You receive legitimate, EMA-approved medications from any licensed EU pharmacy, ensuring product quality and traceability.
- Regulated and secure platform: Hi-Doctor operates under strict RGPD compliance, offering secure, auditable communication within your private patient account.
- Proven trust: With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor is a trusted provider of online medical consultations.
In contrast, unregulated 'research chemical' or grey-market peptide vendors offer no medical oversight, no guarantee of product quality or safety, and expose you to significant health and legal risks. Your health deserves the highest standard of care.
Frequently asked questions
Is Cagrisema legal to buy online in Belgium?
No, CagriSema is not approved for general prescription or sale in Belgium or any other EU country. Purchasing it from unregulated online sources is illegal and highly risky due to unknown product quality and safety.
When will Cagrisema be available by prescription?CagriSema is still undergoing clinical trials and regulatory review with the EMA. There is no definitive timeline, but it could be several years before it receives approval and becomes available by prescription in the EU.
What's the closest approved alternative to Cagrisema?
While no exact match exists due to CagriSema's unique dual action, medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) are currently the most effective and widely available approved options for significant weight loss, offering similar mechanisms of action.
How much does an online weight-loss consultation cost?
An online consultation with an EU-licensed doctor through Hi-Doctor costs a flat fee of €25. This fee is automatically refunded if the doctor determines that treatment is not appropriate for your case.
Can I use a Hi-Doctor prescription at any pharmacy?
Yes, Hi-Doctor issues REMPE electronic prescriptions that are valid at any licensed pharmacy across all EU member states, including Belgium, thanks to the EU's cross-border prescription directive 2011/24/EU.